Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Journal of Cancer|March 14, 2015
Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?Kalliopi Domvri, Dimitrios Bougiouklis, Paul Zarogoulidis, et al.Journal of Cancer|February 10, 2015
Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung CancerWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Joshua Stopek, et al.Diagnostic Pathology|November 15, 2014
A gene therapy induced emphysema model and the protective role of stem cellsPaul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Haidong Huang, et al.BMC Cancer|February 19, 2010
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors modelAristotelis Bamias, Alexandra Karadimou, Sofia Lampaki, et al.Journal of Thoracic Disease|October 23, 2014
Transbronchial lung biopsy and pneumothoraxYong Huang, Haidong Huang, Qiang Li, et al.Cancer Genomics & Proteomics|October 30, 2019
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for TreatmentHelena Linardou, Vassiliki Kotoula, George Kouvatseas, et al.Cancers|July 2, 2021
A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The 'LUNGFUL' StudyGiannis Mountzios, Anna Koumarianou, Alexandros Bokas, et al.JCO Clinical Cancer Informatics|February 3, 2026
SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group StudyParis A Kosmidis, Thanos Kosmidis, Kyriaki Papadopoulou, et al.Lung Cancer (Auckland, N.Z.)|September 13, 2021
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in GreeceGiannis Mountzios, Sofia Lampaki, Georgia-Angeliki Koliou, et al.Anticancer Research|May 29, 2023
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek PatientsHelena Linardou, Sofia Lampaki, Georgia-Angeliki Koliou, et al.Pageof 7